Bei Akademie registrieren
Argenx, NL0010832176

argenx schedules third-quarter results for October 22: what it means for argenx stock

Published on 10/18/2026 at 17:14 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
argenx stock is at EUR 726.60 in weekend trading on October 18, 2026. The company will discuss third-quarter results on October 22, 2026.

Upcoming results date set

  • argenx announced a third-quarter results call for October 22, 2026.
  • argenx stock trades in weekend trading at Lang & Schwarz at EUR 726.60 at 5:11 p.m. CEST on October 18, 2026.
  • The next Xetra session is scheduled for October 19, 2026.
Vogelperspektive-Flatlay: Behandschuhte Hände führen Multikanal-Pipette über 96-Well-Mikrotiterplatte mit blauer Flüssigkeit, weißer Labortisch, symmetrische Komposition
Argenx NL0010832176 Mehrkanal-Pipette befüllt von oben eine blaue 96-Well-Platte im Immunologie-Labor sorgfältig, Illustration mit AI erstellt.

argenx announced on October 15, 2026, that it will discuss its third-quarter 2026 financial results and provide a business update on October 22, 2026, at 2:30 p.m. CET. The announcement was published by argenx.

argenx stock trades in weekend trading at Lang & Schwarz at EUR 726.60 at 5:11 p.m. CEST on October 18, 2026. The next price is shown from the start of trading by the continuously updated real-time quote of argenx stock.

Market context: Market report AEX.

Upcoming company dates

The next Xetra session is scheduled for October 19, 2026. argenx’s third-quarter results and business update are scheduled for October 22, 2026, according to the company’s announcement linked above.

Recent clinical update

On October 8, 2026, argenx reported positive topline results from a Phase 2 study of FB102 in adults with celiac disease. The study met its primary endpoint for the change from baseline in the villus height-to-crypt depth ratio at day 78 versus placebo, with a p-value of 0.0176. The company said it plans to advance FB102 into Phase 3 development, according to GlobeNewswire.

Disclaimer...
en | NL0010832176 | ARGENX | boerse | 70354285 | bgmi